Gilead Receives Regulatory Approvals for Arcellx Deal

Gilead received all required regulatory approvals for its acquisition of Arcellx and extended its tender offer. The update indicates the transaction is moving forward through remaining closing conditions.

The excerpt provides no deal consideration or pricing details, but it confirms regulatory clearance and a continued tender process.